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Background. Grewia asiatica Linn, or phalsa, is a commonly consumed fruit in Pakistan. )e fruit is employed in the traditional
medicine practice of Pakistan as a smooth muscle relaxant in different gastrointestinal (GI) and cardiovascular diseases. In this
investigation, we show the antispasmodic and vasorelaxant actions of Grewia asiatica fruit extract. Methods. A 70% methanolic
crude extract of the plant material was prepared (Ga.Cr). Different isolated GI tissue preparations and endothelium-intact aortas
from rats were utilized to observe the pharmacological actions of the extract. Results. Ga.Cr, in increasing concentrations,
inhibited the spontaneously contracting rabbit jejunum. In an effort to determine the mechanism of this relaxant action,
contractions were induced in jejunum and ileum tissues with K+ (80mM). Ga.Cr was able to only partially inhibit these induced
contractions indicating that the mechanismmight not be completely through a blockade of Ca2+ channels (CCB). When tested on
low K+-(25mM) sustained contractions, Ga.Cr cumulatively suppressed these contractions (0.1–10mg/ml), indicating an opening
of K+ channels (KCO) as the mechanism. Cromakalim, a standard KCO, was also more specific in blocking low K+-induced
contractions. For the effect in aorta tissues, Ga.Cr suppressed the agonist-induced contractions from 0.3mg/ml to 10mg/ml.
Upon challenge with L-NAME, a nitric oxide (NO) blocker, the extract response curve shifted right, indicating vasodilation was
mediated via endothelial NO. Conclusion. )is study shows that GI antispasmodic and vasodilator activities of Ga.Cr may be
mediated via a KCO mechanism in the GI tract and through the release of NO from vascular endothelium.
1. Introduction
Grewia asiatica Linn (family Tiliaceae) is a plant commonly
known and cultivated in South Asia. It is known by the
common name of phalsa in Hindi and Urdu. )e plant
grows into a small tree or shrub around five meters in height.
)e fruit from the tree, also known as phalsa (purple to black
and 1–1.5 cm in diameter), is an edible berry that is very
popular with the people of South Asia. It is known specif-
ically as a cooling agent in the summer months, and people
typically eat the berry raw or consume as juice or syrup. Not
only is the phalsa fruit liked as an edible berry, but the berry
and other parts of the plant, including the bark, leaves, buds,
and roots, are used by traditional healers of the region for
their medicinal benefit [1]. )e bark and roots are known to
relieve inflammation of joints and muscles, the leaves are
useful for infectious skin conditions, and the fruit is known
to be beneficial in indigestion, diarrhea, and cardiac/heart
disorders [1–3].
Some of the pharmacological studies performed on the
plant show its medicinal benefits in anxiety, depression,
memory impairment [4], diabetes, hyperlipidemia [5–8],
pain, fever, inflammation [7, 9, 10], and infections [11, 12].
In terms of the phytochemical constituents, prior studies
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report that Grewia asiatica has several polyphenols [13, 14],
carbohydrates, tannins, vitamin C [15], and different amino
acids [3].
We undertook this project to justify the use of Grewia
asiatica fruit in gastrointestinal (GI) and cardiac disorders.
In the course of our experiments, we found that the 70%
aqueousmethanolic extract ofGrewia asiatica fruit exhibited
antispasmodic activity in isolated GI tissue preparations and
the vasodilator effect in isolated vascular tissues.
2. Materials and Methods
2.1. Animals. A determined effort was undertaken to
minimize the suffering of the animals at every step of this
project. Experiments were performed as detailed in the
European Community guidelines, EEC Directive 86/609/
EEC. Smooth muscle tissues were acquired from local
rabbits weighing around 1 kg and guinea pigs with an av-
erage weight of .5 kg of both sexes were used. Sprague-
Dawley rats of either sex, weighing around 200 g, were also
used. )ese animals were kept in Aga Khan University’s
animal house where the temperature was kept between 23°C
and 25°C, while the conditions were ensured to be pathogen-
free. )e animals were given water as needed. A standard
diet was provided to the animals [16], though it was with-
drawn a day before the experiment.
2.2. Drugs and Reagents. For the experimentation part, the
following standard pharmacological agonists and antago-
nists were used: acetylcholine chloride (ACh), L-NG-nitro
arginine methyl ester (L-NAME), phenylephrine (PE), po-
tassium chloride, and verapamil (all from Sigma, USA).
Tocris and RBI Chemicals were contacted for cromakalim
and glibenclamide, respectively. For the physiologic salt
solutions, Tyrode’s and Krebs’s solutions were used, the
ingredients of which were acquired from Sigma Chemical
Co. and Merck, Germany.
2.3. Crude Extract Preparation. Around 1 kg of phalsa
berries were collected in Karachi, Sind, Pakistan (geo-
graphical coordinates: latitude 24°53′40.3224″N, longitude
67°3′48.906″E (degrees, minutes and seconds, DMS); or Lat
24.894534, Long 67.063585 (decimal degrees, DD)). A
specimen of this was identified and sampled with the
Herbarium of Department of Biological and Biomedical
Sciences, Aga Khan University.
)e phalsa fruit was cleaned, washed, and then lightly
opened up with a pestle. For the process of making an
extract, these were then dipped in a couple of liters of a
mixture of 30% distilled water and 70% methanol (analytical
grade from Merck Co., Darmstadt, Germany) for 72 hours.
At the end of this period, the contents were filtered through a
cloth filter, and the plant material was again dipped in a new
supply of solvent mixture, twice, for 72 hours each. Finally,
all the filtrates were collected and passed through Whatman
filter paper. For the process of concentration, a rotary
evaporator was used. )is resulted in obtaining a viscous
extract coded as Ga.Cr.
2.4. Rabbit Jejunum. We have performed this method of
utilizing isolated rabbit jejunum tissues for pharmacological
testing before [16]. To briefly describe the method here,
pieces of intestinal jejunum around 2 cm long were acquired
from rabbits and hung using cotton thread in glass muscle
baths with Tyrode’s at 37°C. Tyrode’s solution was bubbled
with carbogen gas. A preload of a gram was used on jejunum
segments and were left to stabilize for half an hour and
connected to oscillographs and isotonic force transducers
(Harvard Apparatus, USA). )e tissues were stabilized with
a standard contractile agent ACh (1 μM). Rabbit jejunum is a
tissue that when set up like this elicits spontaneous rhythmic
contractions that help in testing for both spasmolytic and
spasmogenic agents. )e muscle inhibitory effect of the
extract was calculated in comparison to the baseline muscle
contractility, while any possible spasmogenic effect was
compared to the ACh maximum effect.
A potential spasmolytic response from the test extract
was further investigated on contractions sustained in rabbit
jejunum with the help of high K+ (80mM) and low K+
(25mM). Suppression of high K+ indicated a calcium
channel blocking (CCB) effect, and suppression of low K+
indicated a relaxant effect mediated via the opening of K+
channels [17, 18]. )e suppression of these induced con-
tractions by Ga.Cr was calculated as compared to the effect
exhibited by high and low K+.
2.5. Guinea Pig Ileum. We have described working with the
guinea pig ileum in detail before [19]. In summary, 1-2 cm
long pieces of ileum were obtained from guinea pigs. )ese
pieces were maintained in tissue baths, and recordings were
made as described above for rabbit jejunum. Tissues were
kept for 30 minutes to normalize and then stabilized with
repeated doses of a standard agent, ACh (1 μM). A three-
minute gap was allowed between administered concentra-
tions of standard or test agents. Unlike rabbit jejunum,
guinea pig ileum does not exhibit rhythmic contractions but
only shows a flat baseline ideal for testing of potential
spasmogenic agents. Spasmolytic activity can be tested with
the help of an agonist. )is was done the same way as
described with jejunum tissues. Contractions were obtained
with a high strength of K+. Later, the test substance was
administered cumulatively to record for any relaxant
activity.
2.6. Endothelium-Intact Rat Aorta. A previously described
method was followed [20] with some changes [21]. In brief,
aorta tissue was carefully obtained, so that the endothelial
part stayed intact. Tissue of about 3mm width was main-
tained at 37°C in Krebs’s and aerated with carbogen gas.
Baseline tension of a gram was used, and rings were left to
normalize for half an hour. Any changes with the vascular
muscle were recorded with the help of isometric force
transducers (World Precision Instruments Fort 100), linked
with Transbridge 4M and captured through the CVMS data
acquisition system. Standard vasoconstrictor PE (1 μM) was
used for tissue stabilization. While in poststabilization, the
contraction was induced with the same agent. Acetylcholine
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(0.1 μM) was utilized to test endothelial-mediated suppres-
sion of PE contractility. Later, the test extract was admin-
istered on PE contractions in increased concentrations. For
any potential characterization of a vasodilator effect,
L-NAME (0.1mM; 60-minute pretreatment period) was
used as an antagonist to block a potential nitric-oxide- (NO-)
mediated vasodilator effect in the endothelium-intact
preparations.
2.7. Representation of Results. )e results are expressed as
the mean± standard error of the mean, or SEM, while “n” is
the number of observations. )e median effective concen-
trations (EC50) have 95% confidence intervals (CI). Curves
were compared utilizing two-way analysis of variance
(ANOVA) with p< 0.05 suggesting meaningful difference
(GraphPad, USA).
3. Results
3.1. Rabbit Jejunum. Ga.Cr exhibited a spasmolytic effect on
the default spontaneously beating jejunal tissue when used in
increasing concentrations from 0.3mg/ml to 10mg/ml. )e
EC50 for this effect was 4.4mg/ml (3.5–5.3, n� 7). )e ex-
tract concentration of 10mg/ml completely suppressed the
jejunum contractility (Figure 1). High K+ (80mM) was
administered to figure out the reason for this relaxation, and
sustained contractions were obtained. Ga.Cr was then ad-
ministered cumulatively on these contractions. )e extract
from 3mg/ml to 30mg/ml only partially suppressed K+
80mM contractions (Figures 1 and 2). )e EC50 for this
effect was 7.1mg/ml (5.3–9.3, n� 3). In comparison, Ga.Cr
(0.1–10mg/ml) fully suppressed K+ 25mM induced con-
tractions with EC50 of 1.6mg/ml (1.1–2.4, n� 3, Figure 2).
)e action of Ga.Cr on 80mM compared to 25mM was
significantly different (p< 0.0001). )e depressant action of
the extract on 25mMwas blocked (curve shifted to the right;
p< 0.0001 against the control curve) when challenged with
glibenclamide (3 μM) and was only mediated from 3mg/ml
to 30mg/ml. )e EC50 for this response was 7.3mg/ml
(6.4–8.3, n� 3, Figure 2).
Some standard drugs, such as cromakalim and verap-
amil, were also tested for comparison with the extract.
Cromakalim, 0.01–1 μM, suppressed the rhythmic baseline
contractions of the jejunum (Figure 3) with EC50 of 0.23 μM
(0.11–0.47, n� 5). Cromakalim was also cumulatively ad-
ministered on K+ 80mM. It inhibited these contractions
from 0.1 μM to 10 μM.)e EC50 was 7.4 μM (3.6–15.0, n� 5).
In comparison, when cromakalim was administered upon
K+ 25mM contractions (Figure 3), the relaxant effect came
from 0.01 μM to 0.1 μM. )e EC50 for this was 0.03 μM
(0.02–0.05, n� 4, p< 0.0001 when matched with the K+
80mM effect), and this was shifted to the right/blocked
(effect from 0.3 μM to 10 μM, EC50 of 7.3 μM (2.1–25.6,
n� 3) when challenged with glibenclamide (3 μM, p< 0.0001
compared to the control effect).
Verapamil showed its relaxant effect on jejunum baseline
contractions from 0.01 μM 1 μM.)e EC50 for this effect was
0.25 μM (0.20–0.30, n� 7, Figure 3). Verapamil’s effect on
high and low K+-induced contractions (Figure 3) was
exhibited at a similar range of concentrations (p> 0.05),
from 0.01–0.3 μM. )e EC50 value for effect on K+ 80mM
was 0.05 μM (0.04–0.06, n� 7), and the effect on K+ 25mM
was the same at 0.05 μM (0.04–0.06, n� 10).
3.2. Guinea Pig Ileum. Ga.Cr did not show any stimulant
effect on the ileal quiescent tone up to a concentration of
10mg/ml (n� 3, data not shown). On the contrary, Ga.Cr
exhibited a mild and partial relaxant effect (3–30mg/ml,
n� 3) on K+- (80mM) sustained spasmogenicity (Figure 1).
)is effect had the same potency and efficacy shown by
Ga.Cr in rabbit jejunum (p> 0.05). Because of this, further
testing was done only in rabbit jejunum rather than both
tissue preparations.
3.3. Endothelium-Intact Rat Aorta. Ga.Cr did not show any
stimulant effect (n� 3, data not shown) on the default
quiescent tone of the aorta. Later, contractions were induced
by PE (1 μM) in the aorta, which the extract, in increasing
concentrations of 0.3–10mg/ml, relaxed. )e EC50 for this
relaxant effect was 3.9mg/ml (3.0–4.9, n� 4, Figure 4). )is
vasorelaxant action of the extract was repeated in tissues
pretreated with the blocker L-NAME (Figure 4). )is im-
pacted the extract’s vasodilator action as seen by the
switching of the concentration-response effect (p< 0.0001
from control curve). )e vasodilator action of extract in the
presence of the blocker was mediated from 3mg/ml to
30mg/ml, while the EC50 for this was 8.7mg/ml (8.0–9.4,
n� 4, Figure 4).
4. Discussion
Phalsa berries are traditionally known to be beneficial for GI
and cardiovascular ailments [1–3]. For this reason, a study
was planned to investigate if there is any scientific basis for
their use in GI disorders. Our results showed that a 70%
aqueous methanolic crude extract of phalsa fruit concen-
tration-dependently relaxed the spontaneous contractions of
isolated rabbit jejunum tissues (Figure 1). )e rabbit jeju-
num contracts in a spontaneous manner when stabilized and
immersed in a physiologic salt solution under a controlled
environment. )is makes it useful in testing for potential GI
spasmolytic agents [16, 22]. )e crude extract was also tested
on ileal preparations. Guinea pig ileum behaves very dif-
ferently from the rabbit jejunum in the sense that it does not
exhibit spontaneous contractions. )is means that the
guinea pig ileum is not the ideal tissue to test initially for
spasmolytic agents (unless a standard agonist is used) but
rather a good tool to test for the presence of spasmogenic
characteristics [22]. Ga.Cr extract did not show any spas-
mogenic activity, further strengthening the result acquired
in rabbit jejunum.
To characterize this spasmolytic activity of Ga.Cr extract,
spasmogenicity was induced by K+ 80mM in jejunum and
ileum tissues. )e extract was able to concentration-de-
pendently relax; to a certain extent, these induced con-
tractions in the jejunum and ileum preparations (Figure 1).
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)is effect was seen only at higher concentrations in both
the tissues (3–30mg/ml), and the extract was unable to
completely abolish the induced contractions. )e extract
reduced K+ 80mM contraction in the jejunum to 40 ± 7.6%
and in the ileum to 36.7± 2.4% of K+ maximum contrac-
tion. It was clear from this finding that the extract was
unable to completely suppress K+ contractions. As the
extract was equipotent in its response in the jejunum and
ileum, only the jejunum tissue was selected for further
testing.
To further research this spasmolytic action, Ga.Cr was
administered on K+ (25mM) spasmogenicity in rabbit je-
junum. A suppression of K+ (80mM) contractions normally
indicates a Ca2+ channel blocking effect (CCB), while spe-
cific suppression of K+ (25mM) contractions indicates a K+
channel opening (KCO) effect [18, 23]. )e extract
concentration-dependently completely relaxed these
25mM contractions indicating that it can fully suppress
K+ (25mM) but not K+- (80mM) induced contractions
(Figure 2). )is pointed towards a possible specific KCO-
like effect from Ga.Cr extract. Smooth muscle relaxation
via a KCO-like mechanism is known to cause increased K+
exit, which leads to membrane hyperpolarization, reduced
Ca2+ inside the cells, and thus the relaxation of smooth
muscles [24, 25]. To confirm this KCO-like effect, Ga.Cr
response was obtained in tissues pretreated with a stan-
dard potassium channel antagonist/blocker (KCB), gli-
benclamide, which is partially adenosine triphosphate-
(ATP-) dependent KCB [26]. Glibenclamide inhibited the
spasmolytic action of Ga.Cr, evident from the rightward
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Figure 1: )e graphs presenting the activity of Grewia asiatica 70% methanolic extract (Ga.Cr) on isolated intestinal smooth muscle
preparations. )e graph on the top shows the effect of Ga.Cr upon baseline rabbit jejunum spasmogenicity. )e relaxant activity depicted is
the percent of spontaneous contractions of the tissue (results are mean± SEM for 7 observations). )e graph at the bottom shows activity of
the extract on high K+ (80mM) spasmogenicity in jejunal and ileal preparations. )e spasmolytic behaviour of Ga.Cr is % of agonist-
sustained spasmogenicity (results are mean± SEM for 3 observations).
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)e GI smooth muscle relaxant effect of the extract,
possibly mediated via a specific KCO mechanism, was also
compared to two standard smooth relaxants, namely, cro-
makalim and verapamil. Cromakalim is an ATP-sensitive
KCO [27] that causes membrane hyperpolarization and
muscle relaxation. Verapamil is a CCB that exhibits its
smooth muscle relaxant effect via reduced intracellular Ca2+
[28]. Being standard spasmolytics, both the agents sup-
pressed the spontaneous contractions of rabbit jejunum
(Figure 3). Both cromakalim and verapamil also inhibited
the induced contractions from both strengths of K+ (25mM
and 80mM, Figure 3). Of interest is that, similar to Ga.Cr
extract, cromakalim, being a KCO, was more specific in
blocking 25mM concentration-induced contractions than
the 80mM contractions. )is more potent effect on the K+-
(25mM) induced contractions, similar to the extract, was
blocked when the tissues were pretreated with glibencla-
mide, the KCB. Verapamil, on the other hand, inhibited both
25mM and 80mM K+-induced contractions equipotently.
)ese experiments with the standard drugs clearly differ-
entiated a predominant KCO-like effect from that of a CCB
mechanism. )is also confirms our finding that Ga.Cr ex-
tract mediated its GI smooth muscle relaxant effect via a
mixture of KCO and CCB mechanisms with the extract
being more specific in the KCO effect. )is is why it is more
evident in the lower concentration, while the CCB effect is
visible in the higher concentrations.
Different studies have been performed on the Grewia
asiatica fruit to investigate its chemistry. Reports have
shown that the fruit contains phenolic compounds such as
flavonoids, carbohydrates, proteins and amino acids, tan-
nins, vitamin C, fixed oils, and steroids [3, 15, 29]. From
among the class of flavonoid compounds, a number of
compounds have been isolated and identified. Some of these
are isovitexin, luteolin, nepetin, narirutin, hesperetin, cat-
echin, epigallocatechin, kaempferol, myricetin, quercetin
[3, 14, 30], and vitexin [30]. Out of these flavonoids,
quercetin, luteolin [31, 32], and catechin [33] have been
reported to have a CCB activity. )is shows that the CCB
activity seen with Ga.Cr can possibly be attributed to these
chemicals in the phalsa fruit. As for the KCO effect seen with
Ga.Cr, this can most possibly be due to the presence of
vitexin in the phalsa fruit. Vitexin is an apigenin flavone
glucoside. Similar to Ga.Cr extract, vitexin has been shown
to suppress rabbit jejunum contractility in isolated tissues
and exhibit glibenclamide-sensitive relaxation of K+
(25mM) contractions while unable to inhibit K+ 80mM
contractility [34].
)e next round of experiments was conducted on rat
aorta to investigate the effect of Ga.Cr on vascular tissues,
particularly on vascular resistance. Ga.Cr did not exhibit any
constrictor action on the quiescent tone of rat aorta. Once
administered on PE-induced contractions, the extract
showed concentration-dependent relaxation from 0.3mg/ml
to 10mg/ml (Figure 4). )e vasoconstrictor PE is known to
facilitate the entry of Ca2+ into the vascular cells through the
opening of the receptor-operated Ca2+ channel [35]. )e rat
aorta tissues used in the experiments had intact endothe-
lium. )is meant that we could test the involvement of the
vasodilator nitric oxide (NO) which is released from the
vascular endothelium and is responsible for the regulation of
vascular tone [20, 21]. To know if the vasorelaxant action of
the extract came about via NO release, the aorta preparations
were challenged with L-NAME, a NO synthase blocker [36].
Once the blocker L-NAME was left with the tissues, it en-
sured that there is no NO synthesis and thus no NO-me-
diated vascular relaxation. Doing so showed the partial
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Figure 2: )e graph showing how Grewia asiatica 70% methanolic extract (Ga.Cr) suppresses the spasmogenicity of K+ 80mM and 25mM
(with and without the standard antagonist glibenclamide or glib 3 μM) on jejunal tissues of a rabbit. Spasmolytic action of Ga.Cr is the
percent of K+-induced contraction (results are mean± SEM for 3 observations).
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Figure 3: )e graphs representing the activity of different standard spasmolytic agents on isolated rabbit jejunum tissue preparations. )e
graph on the top shows the effect of increasing concentrations of cromakalim upon resting baseline, K+ (80mM) and K+ (25mM)
spasmogenicity, and K+ (25mM) with and without the standard antagonist glibenclamide 3 μM (glib) (results are mean± SEM for 3–5
observations). )e bottom graph showing the effect of verapamil on the resting spontaneous baseline, K+ (80mM), and K+ (25mM)
spasmogenicity (results are mean± SEM for 7–10 observations).
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evident from the rightward shift of concentration-response
curves of Ga.Cr extract in Figure 4. )is indicated in-
volvement of NO release in the vasodilator action of Ga.Cr.
5. Conclusion
)e results from this study showed spasmolytic activity of
70% methanol extract of Grewia asiatica. )is effect was
elucidated in isolated small intestinal GI smooth muscle
tissues. Ga.Cr medicated this effect through a mixture of
KCO and CCB mechanisms, although the extract was more
specific for the former than the latter mechanism of action.
Ga.Cr also showed vasodilator activity in endothelium-in-
tact rat aorta tissue preparations. Ga.Cr exhibited this action
possibly via NO released from vascular endothelium. )ese
results justify the use of Grewia asiatica fruit in disorders of
the GI and cardiovascular systems. Further studies are
needed to run in vivo animal tests and to isolate the pure
chemicals from this plant that are responsible for the
abovesaid actions.
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